---
figid: PMC2361254__94-6603055f4
figlink: /pmc/articles/PMC2361254/figure/fig4/
number: F4
caption: EGFR signalling pathway, including downstream markers and the proposed effects
  of erlotinib.
pmcid: PMC2361254
papertitle: Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal
  cancer.
reftext: C A Townsley, et al. Br J Cancer. 2006 Apr 24;94(8):1136-1143.
pmc_ranked_result_index: '8325'
pathway_score: 0.8853659
filename: 94-6603055f4.jpg
figtitle: EGFR signalling pathway, including downstream markers and the proposed effects
  of erlotinib
year: '2006'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2361254__94-6603055f4.html
  '@type': Dataset
  description: EGFR signalling pathway, including downstream markers and the proposed
    effects of erlotinib.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - EIF2AK3
  - AKT1
  - AKT2
  - EGF
genes:
- word: PPKB/Akt↑
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: PPKB/Akt↑
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PPKB/Akt↑
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: EGF
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
chemicals: []
diseases: []
figid_alias: PMC2361254__F4
redirect_from: /figures/PMC2361254__F4
figtype: Figure
---
